FDA-approved comparator product for glaucoma/ocular hypertension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FDA-approved comparator product for glaucoma/ocular hypertension, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]